U.S. Markets closed

Pfizer expands into cancer space buying Array BioPharma for $10.64 billion

Pfizer has reached an agreement to buy Array Biopharma for $10.64 billion in cash. Yahoo Finance's Ines Ferre joins Seana Smith.